The manufacturer of a generic version of the abortion drug mifepristone sued the Food and Drug Administration on Wednesday to prevent any new restrictions on the pill.
Subscribe to:
Post Comments (Atom)
< + > A Healthcare IT Leader Preview of ViVE 2026
As those who read Healthcare IT Today regularly know, we attend a lot of healthcare IT conferences throughout the year. One of the newest ...
No comments:
Post a Comment